Imagine a future where people with diabetes no longer have to endure the daily discomfort of finger pricks. It's a reality that's closer than you think, thanks to groundbreaking research from MIT. But here's where it gets controversial...
MIT scientists have developed a non-invasive method to measure blood glucose levels, potentially revolutionizing diabetes management. By harnessing the power of Raman spectroscopy, a technique that reveals the chemical composition of tissues, they've created a device that could make finger pricks a thing of the past.
The device, initially the size of a shoebox, uses near-infrared or visible light to measure blood glucose levels without needles. In a recent study, researchers compared its accuracy to commercial continuous glucose monitoring sensors, which require a wire to be implanted under the skin. While the device is currently too large for wearability, the team has since developed a wearable prototype, currently undergoing testing.
"The finger stick has been the standard, but it's an uncomfortable and inconvenient method," says Jeon Woong Kang, an MIT research scientist. "Under-testing can lead to serious complications. A non-invasive glucose monitor with high accuracy would be a game-changer for diabetes management."
The study, led by MIT postdoc Arianna Bresci, is published in the journal Analytical Chemistry. Other contributors include Peter So, director of the MIT Laser Biomedical Research Center, and researchers from Apollon Inc., a South Korean biotechnology company.
And this is the part most people miss...
Most diabetes patients currently measure blood glucose levels by drawing blood and using a glucometer. Some use wearable monitors with sensors inserted under the skin, but these can cause irritation and need replacing every 10-15 days. Researchers at MIT's Laser Biomedical Research Center have been working on non-invasive sensors based on Raman spectroscopy to create more comfortable, long-lasting wearables.
In 2010, LBRC researchers demonstrated a method to indirectly calculate glucose levels by comparing Raman signals from interstitial fluid and blood glucose levels. While reliable, this approach wasn't practical for a wearable monitor. However, a recent breakthrough allowed the team to directly measure glucose Raman signals from the skin, overcoming the challenge of filtering out unwanted signals.
The researchers have since shrunk the device, analyzing just three specific bands in the Raman spectrum. Typically, a Raman spectrum contains around 1,000 bands, but the MIT team found they could accurately determine blood glucose levels by measuring just three bands, reducing equipment costs and size.
"By focusing on specific bands, we've streamlined the process," Bresci explains. "We've saved space, time, and cost, making a more practical and accessible device."
The team's new device was tested in a clinical study at the MIT Center for Clinical Translation Research. Over four hours, the device took readings from a healthy volunteer's arm, with each measurement taking around 30 seconds. The subject consumed two 75-gram glucose drinks, allowing researchers to monitor changes in blood glucose concentration. The Raman-based device showed accuracy similar to two commercially available invasive glucose monitors.
Since then, the researchers have developed a smaller prototype, the size of a cellphone, currently being tested as a wearable monitor in healthy and pre-diabetic volunteers. Next year, they plan to conduct a larger study with a local hospital, including people with diabetes. The team is also working on making the device even smaller, watch-sized, and exploring ways to ensure accurate readings for different skin tones.
The research is funded by the National Institutes of Health, the Korean Technology and Information Promotion Agency for SMEs, and Apollon Inc.
So, what do you think? Could this non-invasive method be the future of diabetes management? We'd love to hear your thoughts in the comments!
